Depletion of PD-1-positive cells ameliorates autoimmune disease

Targeted suppression of autoimmune diseases without collateral suppression of normal immunity remains an elusive yet clinically important goal. Targeted blockade of the programmed death-1 receptor (PD-1) — an immune checkpoint factor expressed by activated T cells and B cells — is an efficacious the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peng, Wang, Peng, Dong, Shuyun, Zhou, Zemin, Cao, Yanguang, Yagita, Hideo, He, Xiao, Zheng, Song Guo, Fisher, Simon J., Fujinami, Robert S., Chen, Mingnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452906/
https://www.ncbi.nlm.nih.gov/pubmed/30952980
http://dx.doi.org/10.1038/s41551-019-0360-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452906/
https://www.ncbi.nlm.nih.gov/pubmed/30952980
http://dx.doi.org/10.1038/s41551-019-0360-0

Ejemplares similares